Company intelligence / Profile preview

QuantHealth

Tel Aviv-Yafo, Tel Aviv, Israel

Ownership: Private
Development stage: Other

Overview

QuantHealth's AI platform can predict clinical trial outcomes with 85% accuracy overall, with 88% accuracy for phase 2 trials (compared to industry average of 28.9%) and 83.2% accuracy for phase 3 trials (versus industry average of 57.8%)

Therapeutic areas: OncologyGastroenterology
Industry: Drug Discovery Services

Partnerships

Accentureunnamed CRO firm

Beyond the preview

Go deeper on QuantHealth.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on QuantHealth.

Explore the full profile